先看重點
這項涵蓋17項統合分析、68項試驗的綜述中,115項關聯裡有51項(44%)具有統計學意義,僅四項有高質量證據支援:甘油三酯降低(2項)、癲癇發作減少(1項)和低密度脂蛋白膽固醇升高(1項)。納入試驗時間短(追蹤中位數13週)、規模小(中位數42名參與者),對心臟事件或生存的長期影響仍然未知。
證據類型
回顧的回顧
解讀依據
公開摘要
閱讀重點
方法與適用範圍
研究在問什麼
隨機試驗的統合分析曾報告生酮飲食對癲癇、超重或肥胖等情況有益,但這些證據整體的強度和質量尚未經過評級。研究者要對已發表統合分析中生酮飲食與健康結局的證據進行分級。
研究對象與方法
隨機臨床試驗統合分析的傘狀綜述。檢索了PubMed、EMBASE、Epistemonikos和Cochrane系統綜述資料庫,截止到2023年2月15日,納入針對生酮飲食(KD)、生酮低碳水高脂飲食(K-LCHF)和極低熱量生酮飲食(VLCKD)的統合分析。用隨機效應模型重新進行統合分析,並用GRADE標準將每項關聯的證據質量評為高、中、低或極低。
主要發現
以下為作者報告的結果。數值須連同族群和不確定性一起閱讀。
- 1共納入17項統合分析、68項試驗和115項獨特關聯。樣本量中位數為42名參與者(四分位距20-104),追蹤時間中位數為13週(四分位距8-36)。115項關聯中有51項(44%)具有統計學意義。
- 2四項關聯有高質量證據:甘油三酯降低(2項)、癲癇發作頻率降低(1項),以及低密度脂蛋白膽固醇升高(1項)。四項有中等質量證據:體重、呼吸交換率和糖化血紅蛋白下降,以及總膽固醇升高。其餘證據質量為極低(26項)至低(17項)。
- 3在超重或肥胖的成年人中,VLCKD與體格測量和心血管代謝結局的改善顯著相關,且未使肌肉量、LDL-C和總膽固醇變差。
- 4K-LCHF與體重和體脂百分比降低相關,但在健康參與者中也伴有肌肉量下降。作者認為LDL-C升高具有臨床意義。
限制與不確定性
- 1納入的試驗時間短、規模小(中位數13週、42名參與者),對心臟病發作、中風和死亡的影響尚不清楚,作者也指出仍需檢驗。
- 2大多數關聯的證據質量為低或極低,因此許多顯著結果可能不夠穩健。
- 3結果因飲食型別和族群而異(超重成人的VLCKD與健康人的K-LCHF),而傘狀綜述無法糾正原始試驗自身的缺陷。
- 4本解讀僅基於摘要。
日常健康啟示
在評級最好的證據中,生酮飲食可靠地降低了甘油三酯和癲癇發作頻率,體重和血糖也朝有利方向變化,但同時升高了LDL膽固醇,且在採用K-LCHF的健康人中還減少了肌肉量。它是否適合你,尤其是患有癲癇、糖尿病或心臟病時,應與臨床醫師共同決定。
如何連結自己的資料
如果採用低碳水化合物飲食,飲食記錄、定期體重以及連續血糖監測或血糖儀可以顯示自己的血糖反應,而LDL膽固醇需要實驗室血液檢查。請在相同空腹條件下比較數月的結果,而不是單次讀數。
如何理解這類證據
多篇回顧可能反覆使用同一試驗,篇數不等於獨立重複驗證次數;應看品質、重疊和各項結果的確定性。
作者的結構化摘要 English
以下英文摘要依所記錄的開放授權轉載,屬於作者原始材料,並非 MoveVitals 解讀。上方已提供研究解讀,分別說明作者結果與本站解釋;重要結論可直接查核原文。
Background
Systematic reviews and meta-analyses of randomized clinical trials (RCTs) have reported the benefits of ketogenic diets (KD) in various participants such as patients with epilepsy and adults with overweight or obesity. Nevertheless, there has been little synthesis of the strength and quality of this evidence in aggregate.
Methods
To grade the evidence from published meta-analyses of RCTs that assessed the association of KD, ketogenic low-carbohydrate high-fat diet (K-LCHF), and very low-calorie KD (VLCKD) with health outcomes, PubMed, EMBASE, Epistemonikos, and Cochrane database of systematic reviews were searched up to February 15, 2023. Meta-analyses of RCTs of KD were included. Meta-analyses were re-performed using a random-effects model. The quality of evidence per association provided in meta-analyses was rated by the GRADE (Grading of Recommendations, Assessment, Development, and Evaluations) criteria as high, moderate, low, and very low.
Results
We included 17 meta-analyses comprising 68 RCTs (median [interquartile range, IQR] sample size of 42 [20-104] participants and follow-up period of 13 [8-36] weeks) and 115 unique associations. There were 51 statistically significant associations (44%) of which four associations were supported by high-quality evidence (reduced triglyceride (n = 2), seizure frequency (n = 1) and increased low-density lipoprotein cholesterol (LDL-C) (n = 1)) and four associations supported by moderate-quality evidence (decrease in body weight, respiratory exchange ratio (RER), hemoglobin A_(1c), and increased total cholesterol). The remaining associations were supported by very low (26 associations) to low (17 associations) quality evidence. In overweight or obese adults, VLCKD was significantly associated with improvement in anthropometric and cardiometabolic outcomes without worsening muscle mass, LDL-C, and total cholesterol. K-LCHF was associated with reduced body weight and body fat percentage, but also reduced muscle mass in healthy participants.
Conclusions
This umbrella review found beneficial associations of KD supported by moderate to high-quality evidence on seizure and several cardiometabolic parameters. However, KD was associated with a clinically meaningful increase in LDL-C. Clinical trials with long-term follow-up are warranted to investigate whether the short-term effects of KD will translate to beneficial effects on clinical outcomes such as cardiovascular events and mortality.
來源與署名
Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials.
Patikorn C, Saidoung P, Pham T, Phisalprapa P, Lee YY, Varady KA, Veettil SK, Chaiyakunapruk N.
BMC medicine · 2023-05-25
DOI: 10.1186/s12916-023-02874-y ↗PubMed · 37231411 ↗Europe PMC · 所記錄的開放授權: cc by ↗摘要著作權歸原作者,依來源紀錄的開放授權轉載。中文譯文協助閱讀,英文摘要供查核術語及具體數值;本站的方法學解釋與作者結論分別呈現。
MoveVitals 編輯解讀 · 健康教育內容 · 未記錄個人臨床審閱
來源查核日期 2026-11-01
實用健康指南
放在一起讀
更早的進食視窗與更大的體重和胰島素獲益相關,優於晚間進食
彙總41項隨機對照試驗(2287名參與者,介入時間中位數8週)發現,限時進食比日常飲食體重低2.15 kg(95%置信區間−2.56至−1.74),而早吃比晚吃體重多降1.15 kg(95%置信區間−1.86至−0.45)。多數試驗較短,只有6個研究組檢驗了早間進食,結局是身體和血液指標,不是心臟病發作或死亡。
BMJ Medicine
限熱量飲食再加上午8點至下午4點進食視窗,1年減重無明顯額外優勢
139名肥胖患者都按限制熱量的飲食進食,其中一組再加上上午8:00至下午4:00的進食視窗,12個月平均體重變化為−8.0 kg,單純限熱量組為−6.3 kg。淨差值−1.8 kg(95%置信區間−4.0至0.4;P=0.11)無統計學意義,該區間既不能排除視窗確有獲益,也不能排除毫無作用。
The New England Journal of Medicine
20人住院試驗:超加工飲食讓人每天多攝取508 kcal並增重
20名成年人在醫院研究病房住了28天,兩種選單各吃2週、想吃多少吃多少:超加工選單讓他們每天多攝取508 kcal(±106,標準誤,P=0.0001),體重增加0.9 kg;未加工選單則讓體重減輕0.9 kg。樣本小、週期短、食物全程由研究方提供,既不能說明日常生活中的長期結果,也無法確定是食物的哪種特點導致多吃。
Cell Metabolism
地中海飲食加橄欖油或堅果與心血管事件減少相關(更正後的試驗)
在7447名55至80歲、心血管風險較高的西班牙成年人中,被分到加特級初榨橄欖油(風險比0.69,95%置信區間0.53至0.91)或加堅果(風險比0.72,0.54至0.95)的地中海飲食組,發生主要心血管事件的風險低於被告知減少脂肪的對照組。試驗存在隨機化失誤,2013年的報告已撤回並重新估算,證據有力但並不完美。
The New England Journal of Medicine

